Intelligence · Clinical Development
Pipeline search results
Programs matching “non-small-cell-lung-cancer” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 211 pipeline programs matching "non-small-cell-lung-cancer" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
BBO-8520
BridgeBio Oncology Therapeutics
Non-small Cell Lung Cancer
1 trial -
BBP-398 with nivolumab
BridgeBio Oncology Therapeutics
Non Small Cell Lung Cancer
1 trial -
BG-60366
BEONE MEDICINES AUS PTY LTD
Non-Small Cell Lung Cancer
1 trial -
C-TIL051
Nektar Therapeutics UK Limited
Metastatic Non Small Cell Lung Cancer
1 trial -
CEA-targeted CAR-T (Intravenous)
Chongqing Precision Biotech Co., Ltd
NSCLC (Advanced Non-small Cell Lung Cancer)
1 trial -
CMP-001
Regeneron UK Limited
Non Small Cell Lung Cancer
1 trial -
CPI-006
Corvus Pharmaceuticals
Non-Small Cell Lung Cancer
1 trial -
CTX-8371
Compass Therapeutics
Non Small Cell Lung Cancer
1 trial -
DS-1205c
Daiichi Sankyo
Non-small Cell Lung Cancer (NSCLC)
1 trial -
Demcizumab
Mereo BioPharma Group plc
Non Small Cell Lung Cancer
1 trial -
ELVN-002
Enliven Therapeutics
HER2 Mutant Non-small Cell Lung Cancer
1 trial -
Etrumadenant
Arcus Biosciences
Non-small Cell Lung Cancer
1 trial -
Etrumadenant
Arcus Biosciences
Non Small Cell Lung Cancer Metastatic
1 trial -
FT536
Zafatek
Non Small Cell Lung Cancer
1 trial -
FT836
Zafatek
Non-Small Cell Lung Cancer
1 trial -
Furmonertinib
ArriVent BioPharma
Non-Small Cell Lung Cancer (NSCLC)
1 trial -
Guadecitabine
United Therapeutics Europe Ltd
Non Small Cell Lung Cancer
1 trial -
HER3-DXd
Daiichi Sankyo
Non-Small Cell Lung Cancer (NSCLC)
1 trial -
Hemay020
Tianjin Hemay Pharmaceutical Co., Ltd
Neoplasms，Non-Small Cell Lung Cancer
1 trial -
I124-NM404
Cellectar Biosciences
Non Small Cell Lung Cancer
1 trial -
IMP3-saRNA (YMN-136) Vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-Small Cell Lung Cancer
1 trial -
INC280 single agent
Novartis Pharmaceuticals
Non-Small Cell Lung Cancer
1 trial -
Itraconazole
United Therapeutics Europe Ltd
Non-small Cell Lung Cancer
1 trial -
JANX008
Janux Therapeutics
Non-Small Cell Lung Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.